These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Outbreak of extended-spectrum beta-lactamase producing Serratia marcescens in an intensive care unit. Pagani L; Luzzaro F; Ronza P; Rossi A; Micheletti P; Porta F; Romero E FEMS Immunol Med Microbiol; 1994 Nov; 10(1):39-46. PubMed ID: 7874077 [TBL] [Abstract][Full Text] [Related]
3. Outbreak of infection by extended-spectrum beta-lactamase SHV-5-producing Serratia marcescens in a Mexican hospital. Espinosa de los Monteros LE; Silva-Sanchez J; Jiménez LV; Rojas T; Garza-Ramos U; Valverde V J Chemother; 2008 Oct; 20(5):586-92. PubMed ID: 19028621 [TBL] [Abstract][Full Text] [Related]
4. Extended-spectrum beta-lactamases conferring resistance to monobactams and oxyimino-cephalosporins in clinical isolates of Serratia marcescens. Luzzaro F; Pagani L; Porta F; Romero E J Chemother; 1995 Jun; 7(3):175-8. PubMed ID: 7562009 [TBL] [Abstract][Full Text] [Related]
5. Extended-spectrum beta-lactamase-producing Serratia marcescens outbreak in a Bulgarian hospital. Ivanova D; Markovska R; Hadjieva N; Schneider I; Mitov I; Bauernfeind A J Hosp Infect; 2008 Sep; 70(1):60-5. PubMed ID: 18602186 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for extended-spectrum beta-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit. Crivaro V; Bagattini M; Salza MF; Raimondi F; Rossano F; Triassi M; Zarrilli R J Hosp Infect; 2007 Oct; 67(2):135-41. PubMed ID: 17884248 [TBL] [Abstract][Full Text] [Related]
7. A nosocomial outbreak of Serratia marcescens producing inducible Amp C-type beta-lactamase enzyme and carrying antimicrobial resistance genes within a class 1 integron. Bagattini M; Crispino M; Gentile F; Barretta E; Schiavone D; Boccia MC; Triassi M; Zarrilli R J Hosp Infect; 2004 Jan; 56(1):29-36. PubMed ID: 14706268 [TBL] [Abstract][Full Text] [Related]
8. Dissemination of cephalosporin-resistant Serratia marcescens strains producing a plasmidic SHV type beta-lactamase in Greek hospitals. Gianneli D; Tzelepi E; Tzouvelekis LS; Mentis AF; Nikolopoulou C Eur J Clin Microbiol Infect Dis; 1994 Sep; 13(9):764-7. PubMed ID: 7843183 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology and molecular characterization of extended-spectrum beta-lactamase-producing Enterobacter spp., Pantoea agglomerans, and Serratia marcescens isolates from a Bulgarian hospital. Markovska RD; Stoeva TJ; Bojkova KD; Mitov IG Microb Drug Resist; 2014 Apr; 20(2):131-7. PubMed ID: 24171449 [TBL] [Abstract][Full Text] [Related]
10. The ICU environment contributes to the endemicity of the " Aracil-Gisbert S; Fernández-De-Bobadilla MD; Guerra-Pinto N; Serrano-Calleja S; Pérez-Cobas AE; Soriano C; de Pablo R; Lanza VF; Pérez-Viso B; Reuters S; Hasman H; Cantón R; Baquero F; Coque TM mBio; 2024 May; 15(5):e0305423. PubMed ID: 38564701 [No Abstract] [Full Text] [Related]
11. Prevalence and characterization of extended spectrum β-lactamases in Klebsiella-Enterobacter-Serratia group bacteria, in Algeria. Nedjai S; Barguigua A; Djahmi N; Jamali L; Zerouali K; Dekhil M; Timinouni M Med Mal Infect; 2012 Jan; 42(1):20-9. PubMed ID: 22056377 [TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology of an outbreak of Serratia marcescens in a neonatal intensive care unit. Villari P; Crispino M; Salvadori A; Scarcella A Infect Control Hosp Epidemiol; 2001 Oct; 22(10):630-4. PubMed ID: 11776349 [TBL] [Abstract][Full Text] [Related]
13. Outbreak of Serratia marcescens Coproducing ArmA and CTX-M-15 Mediated High Levels of Resistance to Aminoglycoside and Extended-Spectrum Beta-Lactamases, Algeria. Batah R; Loucif L; Olaitan AO; Boutefnouchet N; Allag H; Rolain JM Microb Drug Resist; 2015 Aug; 21(4):470-6. PubMed ID: 25884511 [TBL] [Abstract][Full Text] [Related]
14. Nosocomial outbreak of ceftazidime-resistant Serratia marcescens strains that produce a chromosomal AmpC variant with N235K substitution. Yatsuyanagi J; Saito S; Konno T; Harata S; Suzuki N; Kato J; Amano K Jpn J Infect Dis; 2006 Jun; 59(3):153-9. PubMed ID: 16785694 [TBL] [Abstract][Full Text] [Related]
15. Institutional spread of clonally related Serratia marcescens isolates with a novel AmpC cephalosporinase (S4): a 4-year experience in Taiwan. Yu WL; Ko WC; Cheng KC; Chen HE; Lee CC; Chuang YC Diagn Microbiol Infect Dis; 2008 Aug; 61(4):460-7. PubMed ID: 18455901 [TBL] [Abstract][Full Text] [Related]
16. Outbreak of Serratia marcescens colonization and infection traced to a healthcare worker with long-term carriage on the hands. de Vries JJ; Baas WH; van der Ploeg K; Heesink A; Degener JE; Arends JP Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1153-8. PubMed ID: 17080370 [TBL] [Abstract][Full Text] [Related]
17. First nosocomial outbreak of VIM-16-producing Serratia marcescens in Argentina. Nastro M; Monge R; Zintgraff J; Vaulet LG; Boutureira M; Famiglietti A; Rodriguez CH Clin Microbiol Infect; 2013 Jul; 19(7):617-9. PubMed ID: 22862810 [TBL] [Abstract][Full Text] [Related]
18. Protracted Regional Dissemination of GIM-1-Producing Serratia marcescens in Western Germany. Wendel AF; Kaase M; Autenrieth IB; Peter S; Oberhettinger P; Rieber H; Pfeffer K; MacKenzie CR; Willmann M Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956426 [TBL] [Abstract][Full Text] [Related]
19. Outbreak of multidrug-resistant Serratia marcescens infection in a neonatal intensive care unit. Maragakis LL; Winkler A; Tucker MG; Cosgrove SE; Ross T; Lawson E; Carroll KC; Perl TM Infect Control Hosp Epidemiol; 2008 May; 29(5):418-23. PubMed ID: 18419363 [TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology of Serratia marcescens in two hospitals in Gdańsk, Poland, over a 5-year period. Naumiuk L; Baraniak A; Gniadkowski M; Krawczyk B; Rybak B; Sadowy E; Samet A; Kur J J Clin Microbiol; 2004 Jul; 42(7):3108-16. PubMed ID: 15243068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]